C14-4
C14-4 (C14-494) is an ionizable lipid nanoparticle formulation designed for the efficient delivery of chimeric antigen receptor (CAR) mRNA into primary human T cells. This tool is utilized in both in vitro and in vivo research for advancing adoptive T cell therapies and immunology studies.
Product Specifications
CAS Number
2639634-80-1
Product Name Alternative
C144, C14494, C14-494
Field of Research
Metabolism Research, Signal Transduction
Purity
99.43% (May vary between batches)
Solubility
DMSO:80 mg/mL (58.6 mM) ; Ethanol:80 mg/mL (58.6 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (2.42 mM)
Smiles
OC (CN (CCOCCN (CC (O) CCCCCCCCCCCC) CC (O) CCCCCCCCCCCC) CCN1CCN (CCOCCN (CC (O) CCCCCCCCCCCC) CC (O) CCCCCCCCCCCC) CC1) CCCCCCCCCCCC
Molecular Formula
C84H173N5O7
Molecular Weight
1365.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2149189-01 0.1 mL
PE-Linked Monoclonal Antibody to Cluster of Differentiation 90 (CD90)
Sign In for Pricing
View Details MBS2149189-02 0.2 mL
PE-Linked Monoclonal Antibody to Cluster of Differentiation 90 (CD90)
Sign In for Pricing
View Details 
MBS2149189-03 0.5 mL
PE-Linked Monoclonal Antibody to Cluster of Differentiation 90 (CD90)
Sign In for Pricing
View Details 
MBS2149189-04 1 mL
PE-Linked Monoclonal Antibody to Cluster of Differentiation 90 (CD90)
Sign In for Pricing
View Details